SCHEMBL3650418

SCHEMBL3650418

CC1CCC[N+]1(c1ccc(NC(=O)CC2CCCC2)cc1)C1CCNC1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.48
RAB9A P51151 3/20 0.47
NPC1 O15118 3/20 0.47
KMT2A Q03164 3/20 0.47
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NAMPT P43490 4/20 0.40
TDP1 Q9NUW8 1/20 0.40
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3650317 0.94 EPHX2 (0.43) EPHX2RAB9ANPC1KMT2AMEN1
SCHEMBL3650309 0.85 KMT2A (0.50) EPHX2RAB9ANPC1KMT2AMEN1
SCHEMBL3655137 0.85 RAB9A (0.43) EPHX2RAB9ANPC1KMT2AMEN1
SCHEMBL3662226 0.82 EPHX1 (0.49) EPHX2RAB9ANPC1KMT2AMEN1
Trifluoroacetic Acid SCHEMBL3653647 0.81 KMT2A (0.45) EPHX2RAB9ANPC1KMT2AMEN1
SCHEMBL3657680 0.80 RAB9A (0.51) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL3658860 0.79 JAK3 (0.43)
SCHEMBL3653079 0.78 RAB9A (0.50) RAB9ANPC1KMT2AMEN1CYP3A4
Trifluoroacetic Acid SCHEMBL3655787 0.78 MLYCD (0.46) RAB9ANPC1KMT2AMEN1CYP1A2
SCHEMBL2636793 0.77 BCL9 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212283-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2010-08-04 EP claimed
WO-2009052062-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-04-23 WO claimed
EP-2212283-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2010-08-04 EP disclosed
WO-2009052062-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-04-23 WO disclosed